This Special Issue is designed to highlight the latest research and development on new antifungal compounds with mechanisms of action different from the ones of polyenes, azoles, and echinocandins. The papers presented here highlight new pathways and targets that could be exploited for the future development of new antifungal agents to be used alone or in combination with existing antifungals. A computational model for better predicting antifungal drug resistance is also presented
Clinically available antifungals have a restricted range of efficacy, substantial toxicity, and emer...
From the publisher\u27s website: Infections caused by pathogenic fungi are a significant global prob...
Fungal pathogens are an underappreciated contributor to infectious disease related deaths, infecting...
This Special Issue is designed to highlight the latest research and development on new antifungal co...
This Special Issue of Pharmaceuticals describes recent advances accomplished in the field of antifun...
Fungal infections such as candidoses can range from superficial mucous membrane infection to life-th...
The utility of clinically available antifungals is limited by their narrow spectrum of activity, hig...
Recent investigations have yielded both profound insights into the mechanisms required by pathogenic...
Background: Fungi are the most insidious pathogens, since they are eukaryotic microorganisms. System...
Click on the DOI link to access the article (may not be free).New data suggest that the global incid...
Fungi have emerged worldwide as increasingly frequent causes of healthcare-associated infections, bu...
The rate of fungal infections is increasing rapidly, and pathogenesis of their species is poorly und...
PubMedID: 27837500By definition, an antifungal agent is a drug that selectively destroys fungal path...
Fungal infections of skin are most common dermatological problems in this world. It has been investi...
The emergence of drug-resistant fungi poses a major threat to human health. Despite advances in prev...
Clinically available antifungals have a restricted range of efficacy, substantial toxicity, and emer...
From the publisher\u27s website: Infections caused by pathogenic fungi are a significant global prob...
Fungal pathogens are an underappreciated contributor to infectious disease related deaths, infecting...
This Special Issue is designed to highlight the latest research and development on new antifungal co...
This Special Issue of Pharmaceuticals describes recent advances accomplished in the field of antifun...
Fungal infections such as candidoses can range from superficial mucous membrane infection to life-th...
The utility of clinically available antifungals is limited by their narrow spectrum of activity, hig...
Recent investigations have yielded both profound insights into the mechanisms required by pathogenic...
Background: Fungi are the most insidious pathogens, since they are eukaryotic microorganisms. System...
Click on the DOI link to access the article (may not be free).New data suggest that the global incid...
Fungi have emerged worldwide as increasingly frequent causes of healthcare-associated infections, bu...
The rate of fungal infections is increasing rapidly, and pathogenesis of their species is poorly und...
PubMedID: 27837500By definition, an antifungal agent is a drug that selectively destroys fungal path...
Fungal infections of skin are most common dermatological problems in this world. It has been investi...
The emergence of drug-resistant fungi poses a major threat to human health. Despite advances in prev...
Clinically available antifungals have a restricted range of efficacy, substantial toxicity, and emer...
From the publisher\u27s website: Infections caused by pathogenic fungi are a significant global prob...
Fungal pathogens are an underappreciated contributor to infectious disease related deaths, infecting...